Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy

No abstract is available for this paper.

• Publication year

  2000

• Venue

  British Journal of Dermatology

• Publication date

  2000-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2133.2000.03241.xPMID 10651694
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent Advances in Atopic Dermatitis

  1997cited by this paper
• Long‐term efficacy and safety of cyclosporin in severe adult atopic dermatitis

  1997cited by this paper
• Cyclosporine in severe childhood atopic dermatitis: a multicenter study.

  1996cited by this paper
• Consensus conference on cyclosporin A microemulsion for psoriasis, June 1996

  1996cited by this paper
• Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis *

  1996cited by this paper
• Measures of the effect of adult severe atopic eczema on quality of life

  1996cited by this paper
• The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use

  1995cited by this paper
• Recent advances in atopic dermatitis.

  1994cited by this paper
• Traditional Chinese medicine for eczema

  1994cited by this paper
• What do members of the National Eczema Society really want?

  1993cited by this paper
• Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double‐blind, placebo‐controlled trial

  1993cited by this paper
• Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis.

  1991cited by this paper

• Cyclosporine use in paediatric dermatologic conditions: A comprehensive review of therapeutic applications.

  2026cites this paper
• Cyclosporine in dermatology: Evidence-based review with a special focus on recent updates

  2025cites this paper
• Update on conventional therapy for atopic dermatitis

  2025cites this paper
• Oral Cyclosporine in Vernal Keratoconjunctivitis: Indications, Outcomes, and Effect on Corticosteroid Use.

  2025cites this paper
• Standardtherapie der atopischen Dermatitis - ein Update

  2025cites this paper
• Standardising the diagnosis and management of atopic dermatitis in India: A consensus statement by the modified Delphi method by IADVL Special Interest Group of Pediatric Dermatology (STAND AD).

  2025cites this paper
• Atopic Dermatitis Part 2: Management.

  2025cites this paper
• Long‐Term Safety and Efficacy of Dupilumab in Pediatric Atopic Dermatitis Patients

  2025cites this paper
• Systemic Therapy for Atopic Dermatitis in Children and Adolescents: A US Expert Consensus

  2024cites this paper
• Prurit et douleur cutanée au cours de la dermatite atopique

  2024cites this paper
• The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children - results from the TREAT trial.

  2024cites this paper
• A systematic review investigating the proportion of clinical images shared in prospective randomized controlled trials involving patients with atopic dermatitis and systemic pharmacotherapy

  2024cites this paper
• English version of clinical practice guidelines for the management of atopic dermatitis 2024

  2024cites this paper
• Integrative Approaches to Sleep Management in Skin Disease: Systematic Review

  2023cites this paper
• Uso da ciclosporina em crianças e adolescentes com dermatite atópica moderada a grave: experiência clínica em hospital terciário

  2023cites this paper
• Consenso sobre o manejo terapêutico da dermatite atópica – Sociedade Brasileira de Dermatologia: atualização sobre fototerapia e terapia sistêmica utilizando o método e‐Delphi

  2023cites this paper
• Effectiveness of systemic treatments on pruritus associated with atopic dermatitis: A systematic review in pediatric patients

  2023cites this paper
• Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre, parallel group, assessor-blinded clinical trial.

  2023cites this paper
• Use of cyclosporine in children and adolescents with moderate to severe atopic dermatitis: clinical experience in a tertiary Hospital

  2023cites this paper
• Systemic treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials.

  2023cites this paper
• Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents

  2023cites this paper
• Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP)

  2022cites this paper
• Role of Cyclosporine (CsA) in Immuno-dermatological Conditions

  2022cites this paper
• Treatment algorithms for special cases

  2022cites this paper
• Atopic Dermatitis and Allergic Contact Dermatitis

  2022cites this paper
• Clinical phenotypes of adult atopic dermatitis and related therapies

  2022cites this paper
• National Saudi Consensus Statement on the Management of Atopic Dermatitis (2021)

  2022cites this paper
• English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021

  2022cites this paper
• Therapeutic approach to atopic dermatitis in children

  2022cites this paper
• A comprehensive review of immunosuppressive drugs in pediatric dermatoses: Part I - Corticosteroids, azathioprine, and cyclosporine-A

  2022cites this paper
• Aktualisierung„ Systemtherapie bei Neurodermitis“ zur S2k‐Leitlinie Neurodermitis

  2021cites this paper
• Update on the Pathogenesis and Therapy of Atopic Dermatitis

  2021cites this paper
• Update “Systemic treatment of atopic dermatitis” of the S2k‐guideline on atopic dermatitis

  2021cites this paper
• Association Between Atopic Dermatitis and Height, Body Mass Index, and Weight in Children.

  2021cites this paper
• Probiotics for Atopic Dermatitis: An Update

  2021cites this paper
• 소아 아토피피부염의 최신 치료

  2021cites this paper
• A New Approach to Atopic Dermatitis Control with Low-Concentration Propolis-Loaded Cold Cream

  2021cites this paper
• Association between atopic dermatitis and hypertension: a systematic review and meta‐analysis *

  2021cites this paper
• Atopic dermatitis. Clinical guidelines

  2021cites this paper
• Study on safety and efficacy of low dose oral cyclosporine for the treatment of prurigo nodularis in Bangladeshi population

  2021cites this paper
• When topical therapy of atopic dermatitis fails: a guide for the clinician

  2021cites this paper
• Current Perspectives on the Systemic Management of Atopic Dermatitis

  2021cites this paper
• Current Clinical Options for the Management of Itch in Atopic Dermatitis

  2021cites this paper
• Systemic treatments in the management of atopic dermatitis: A systematic review and meta‐analysis

  2020cites this paper
• A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient‐Education Network in Dermatology (OPENED) task force

  2020cites this paper
• Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open‐label phase IIa study and subsequent phase III open‐label extension study

  2020cites this paper
• results from an open label phase IIa study and subsequent phase III open label extension study

  2020cites this paper
• Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part II. Systemic treatment and new therapeutic methods

  2020cites this paper
• Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies.

  2020cites this paper
• Novel systemic therapies in atopic dermatitis(cid:403) what do we need to fulfil the promise of a treatment revolution(cid:412) (cid:446)version

  2020cites this paper
• Management of severe atopic dermatitis in adult patients

  2020cites this paper
• Cyclosporine shows benefit as compared to methotrexate for treatment of pediatric atopic dermatitis refractory to topical medications when rapidity of clinical response is of key importance to the patient

  2020cites this paper
• TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema

  2019cites this paper
• Relative efficacy of systemic treatments for atopic dermatitis.

  2019cites this paper
• Systematic review about 10 interventions in dermatitis. A document from the Latin American Society of Allergy, Asthma, and Immunology.

  2019cites this paper
• Outcomes of prolonged and low-dose ciclosporin in an Asian population

  2019cites this paper
• Strategies for Successful Management of Severe Atopic Dermatitis.

  2019cites this paper
• Guidelines on Management of Atopic Dermatitis in India: An Evidence-Based Review and an Expert Consensus

  2019cites this paper
• Pediatrics

  2019cites this paper
• Childhood atopic dermatitis: current developments, treatment approaches, and future expectations

  2019cites this paper
• Current therapeutic paradigm in pediatric atopic dermatitis: Practical guidance from a national expert panel.

  2019cites this paper
• PROMIS pediatric measures validated in a longitudinal study design in pediatric oncology

  2019cites this paper
• Pharmacoeconomics of Occupational Diseases

  2019cites this paper
• Clinical practice guidelines for the management of atopic dermatitis 2018

  2019cites this paper
• British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018

  2019cites this paper
• Management of Atopic Dermatitis

  2019cites this paper
• Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative

  2019cites this paper
• Update of Treatment Options in Atopic Dermatitis: A Narrative Review

  2019cites this paper
• Tratamento sistémico do eczema atópico grave em idade pediátrica

  2019cites this paper
• Monitoring trough levels in cyclosporine for atopic dermatitis: A systematic review

  2019cites this paper
• Novel systemic therapies in atopic dermatitis: what do we need to fulfil the promise of a treatment revolution?

  2019cites this paper
• When managing atopic dermatitis-related itch, use a step-wise approach, address barrier repair and educate patients

  2018cites this paper
• When managing atopic dermatitis-related itch, use a step-wise approach, address barrier repair and educate patients

  2018cites this paper
• Drug survival and postdrug survival of first‐line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine

  2018cites this paper
• A randomized controlled trial protocol assessing the effectiveness, safety and cost‐effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)

  2018cites this paper
• The Turkish guideline for the diagnosis and management of atopic dermatitis-2018

  2018cites this paper
• Systemic treatments for eczema: a network meta-analysis.

  2018cites this paper
• Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

  2018cites this paper
• Drug Therapy: Systemic

  2018cites this paper
• A comparison of international management guidelines for atopic dermatitis

  2018cites this paper
• Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

  2018cites this paper
• Management of Itch in Atopic Dermatitis

  2018cites this paper
• Oral Agents for Atopic Dermatitis: Current and in Development

  2018cites this paper
• Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis

  2018cites this paper
• Cyclosporine-A for severe childhood atopic dermatitis: clinical experience on efficacy and safety profile

  2018cites this paper
• Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections.

  2018cites this paper
• Managing sleep disturbances in children with atopic dermatitis

  2018cites this paper
• From folklore to pharmacy: Putting plants into practice.

  2018cites this paper
• Tratamento da Dermite Atópica Moderada a Grave em Adultos

  2018cites this paper
• Nucleophosmin modulates the alleviation of atopic dermatitis caused by the marine-derived compound dihydroaustrasulfone alcohol

  2018cites this paper
• Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center

  2017cites this paper
• Cyclosporine A for severe atopic dermatitis in children. efficacy and safety in a retrospective study of 63 patients

  2017cites this paper
• Liječenje atopijskog dermatitisa

  2017cites this paper
• Non-topical management of recalcitrant paediatric atopic dermatitis

  2017cites this paper
• Systemic Therapy of Atopic Dermatitis: When, How, for How Long?

  2017cites this paper
• Atopic dermatitis: phototherapy and systemic therapy

  2017cites this paper
• Adjunctive Management of Itch in Atopic Dermatitis.

  2017cites this paper
• Long-Term Treatment of Atopic Dermatitis.

  2017cites this paper
• Patient Burden of Atopic Dermatitis.

  2017cites this paper
• Extramammary Paget's disease of vulva: A rare entity

  2017cites this paper